Hartford Balanced Income A HBLAX

Medalist Rating as of | See Hartford Funds Investment Hub
  • NAV / 1-Day Return 15.23  /  −0.07 %
  • Total Assets 12.7 Bil
  • Adj. Expense Ratio
    0.880%
  • Expense Ratio 0.880%
  • Distribution Fee Level Below Average
  • Share Class Type Front Load
  • Category Moderately Conservative Allocation
  • Investment Style Large Value
  • Credit Quality / Interest Rate Sensitivity Medium/Moderate
  • Status Open
  • TTM Yield 3.36%
  • Turnover 57%

USD | NAV as of Oct 02, 2024 | 1-Day Return as of Oct 02, 2024, 10:25 PM GMT+0

Morningstar’s Analysis HBLAX

Will HBLAX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

A step above.

Associate Analyst Nour Al Twal

Nour Al Twal

Associate Analyst

Summary

Capable managers and expansive resources support Hartford Balanced Income’s disciplined approach, but some shares’ big price tags reduce the appeal.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings HBLAX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 11.7
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Usd

1.64 208.6 Mil
Cash and Equivalents

JPMorgan Chase & Co

1.59 202.3 Mil
Financial Services

UnitedHealth Group Inc

1.41 179.0 Mil
Healthcare

Pfizer Inc

1.37 174.0 Mil
Healthcare

ConocoPhillips

1.35 171.4 Mil
Energy

Johnson & Johnson

1.27 161.2 Mil
Healthcare

2 Year Treasury Note Future Dec 24

1.16 147.4 Mil
Government

Cisco Systems Inc

0.97 123.1 Mil
Technology

Merck & Co Inc

0.89 113.0 Mil
Healthcare

Gilead Sciences Inc

0.87 111.4 Mil
Healthcare

Sponsor Center